CRISPR

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: J&J’s imminent vaccine data, CRISPR’s confusing boom, and navigating scientific misinformation

First Opinion By Chris Bakerlee

Mother Nature is not ‘the ultimate bioterrorist’

Biotech By Adam Feuerstein

Preliminary but ‘nothing short of great.’ New data on CRISPR treatment for blood diseases suggest cure is possible

In the Lab By Associated Press

Lab tests show risks of using CRISPR gene editing on embryos

Biotech By Adam Feuerstein

CRISPR Therapeutics’ CAR-T treatment shows encouraging results, but one death is tied to therapy

First Opinion By Patrick Skerrett

The CRISPR Nobel was about more than two women scientists. It was about all of them

In the Lab By Elizabeth Cooney

‘A terrific choice’: George Church salutes fellow CRISPR pioneers’ historic Nobel win

Health By Matthew Herper

Jennifer Doudna, now a Nobel winner, on CRISPR and its role in medical research

Biotech By Andrew Joseph

Patent board delivers blow to University of California over its CRISPR invention claims

First Opinion By Josephine Johnston

The U.S. must do some heavy lifting to prepare for heritable genome editing

Health By Andrew Joseph

Expert panel lays out guidelines for germline editing, while warning against pursuit of ‘CRISPR babies’

In the Lab By Gideon Gil

Virtual Event: CRISPR’s forward march

In the Lab By Sharon Begley

Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases

In the Lab By Sharon Begley

In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys

Biotech By Jonathan Saltzman — Boston Globe

Verve, raising another $63 million, seeks to advance gene-editing treatment for heart disease

First Opinion By Matthias Evers and Michael Chui

The Bio Revolution is changing business and society

Biotech By Sharon Begley

Deluge of genome editing therapies ends research drought for sickle cell disease

Health By Sharon Begley

New CRISPR-based test for Covid-19 could be a simple, cheap at-home diagnostic, scientists say

Health By Rebecca Robbins, Damian Garde, and Adam Feuerstein

‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film

First Opinion By Neal Baer

Covid-19 is scary. Could a rogue scientist use CRISPR to conjure another pandemic?

In the Lab By Associated Press

In its first use inside the human body, CRISPR genome editing tested as blindness therapy

Biotech By Jonathan Saltzman — Boston Globe

Beam Therapeutics raises $180 million in IPO

The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola

First Opinion By Josiah Zayner

CRISPR babies scientist He Jiankui should not be villainized — or headed to prison

First Opinion By Josephine Johnston

He Jiankui is going to jail. Would the U.S. criminally prosecute a rogue gene-editing researcher?